EFFECT OF PROBIOTIC SUPPLEMENTATION ON THE FASTING BLOOD

Imperial Journal of Interdisciplinary Research (IJIR) Vol-3, Issue-4, 2017 ISSN: 2454-1362, http://www.onlinejournal.in

Effect of Probiotic supplementation on the fasting blood glucose and immune status in Type II diabetes mellitus. M Shiva Prakash1*, P Amruth Rao2, K B Chathyushya,3 G Haricharan4, G Madhavi5, G Sumalata6, M Sravanthi7, M Mounika8, P Sai Tejaswi9 & R Hemalatha10 1,2,3,5,6&10

Department of Microbiology & Immunology, National Institute of Nutrition(ICMR), JamaiOsmania (P.O), Tarnaka, Hyderabad-07, Telangana, India. 4 Seasons Hospitals, Street no 7, Vaibhav Nagar Colony, Bagh Amberpet, Hyderabad-13, Telangana. 7-9 Project Trainees, KL University, Green Fields, Vaddeswaram, Guntur-02, A.P, India Abstract: Diabetes mellitus is a worldwide, affecting almost all major sections of society and have an association with cell mediated responses (CMI). Adenosine deaminase (ADA), an enzyme which is a good marker of cell mediated immunity. Probiotics have recently emerged as the prospective bio therapeutics with proven efficacy. The present study is to assess the effect of probiotic curd on blood glucose levels and immune status in diabetes mellitus. A total of about 50 individuals in the age group between 30-50 years of either sex were selected and divided into two groups i.e. with and without diabetes. The subjects in the intervention group were supplemented with 100 gm/day of probiotic curd (Lactobacillus bulgaricus & Streptococcus thermophilus). The fasting blood samples were analyzed for glucose along with ADA before and after supplementation. The results indicated that there was a significant decrease in the blood glucose levels in the supplemented group in comparison with non-supplemented group of diabetes. It has been concluded that Probiotic curd has a significant role in the management of blood glucose and on immune status in Diabetes mellitus. Key Words: Type-II Diabetes, Probiotics, Adenosine deaminase. 1. Introduction

Adenosine deaminase (ADA) is an enzyme distributed in all the human tissues and considered as an important immuno-enzyme marker of cell mediated immunity [2]. Probiotics are recently emerged as the prospective bio therapeutics with proven efficacy demonstrated in various in vitro and in vivo animal models adequately supported with their established multifunctional roles and mechanism of action for the prevention and disease treatment [3]. Few studies were found the Lactic Acid Bacteria (LAB) as a treatment for diabetes especially in experimental animals, despite the evidence showing that they have the potential to reduce the incidence of diabetes [4,5,6]. This study highlighted the new developments in probiotic interventions and prospects for exploring probiotherapy in the prevention and/or control of lifestyle diseases like T2D. 2. Materials & Methods 2.1. Preparation of Probiotic Curd: The Probiotic curd was prepared by fermenting the pasteurized milk with Lactobacillus bulgaricus (UBLB-38) (1x106cfu/gm) and Streptococcus thermophilus (UBST-50) (1x107cfu/gm) for 5-6 hours at 40-450C. Photograph showing 100g probiotic curd container box supplied for subjects under study

Diabetes is a major metabolic syndrome affecting almost all socioeconomic groups worldwide. It is of multifactorial origin, including genetic and environmental factors. As of 2014, it was estimated that about 387 million people have diabetes worldwide, with type 2 diabetes of about 90% of the cases. Immunological disturbances in type 2 Diabetes Mellitus have an association with cell mediated responses and inappropriate Tlymphocyte function which is vital in this pathogenic condition and has a link with insulin defect [1].

Imperial Journal of Interdisciplinary Research (IJIR)

Page 1244

Imperial Journal of Interdisciplinary Research (IJIR) Vol-3, Issue-4, 2017 ISSN: 2454-1362, http://www.onlinejournal.in 2.2. Selection of subjects 2.2.1. Inclusion Criteria: Subjects with not less than 1 year onset of diabetes and no change in oral anti-diabetic medications during the last 6 months) *Age 30 to 60 years *Provision of written informed consent Exclusion criteria: *Chronic gastrointestinal disease (except irritable bowel syndrome) *Antibiotics and probiotics usage within 6 weeks before inclusion *Regular intake of insulin or insulin analogues. *Other secondary health complications such as hypertension, Cardio Vascular Diseases and Thyroid were excluded from the study. 2.2.2. Study Design: This is a case-control study in which a total of about 50 individuals in the age group between 30-50 years of either sex was recruited in and around Hyderabad. These were divided into two groups i.e. with (Group A) and without (Group B) Type-2 Diabetes. The subjects with Diabetes are sub grouped as Group A1 (Supplemented) and Group A2 (NonSupplemented). All the individuals were allowed to take their regular diet. 2.3. Supplementation: The subjects in Group A1 were supplemented with about 100gm/day of freshly prepared probiotic curd (LB+ST) for 30days. They were advised to stop consuming alcohol. Group A2 (non-supplemented) individuals are asked to take milk and/or other curds along with their regular diet. Both the groups are advised to continue their regular medication. 2.4. Laboratory Investigations: About 2 ml of fasting blood samples were drawn into vacutainer tubes at before and after supplementation and subjected to centrifugation at 3,000 rpm for 10 min for serum separation. The Blood Glucose test [7] and ADA estimation [8] were carried out using commercially available kits. 2.5. Subject withdrawal: Subjects were given the liberty to withdraw at any point of time in case of any inconvenience during the study. 2.5. Statistical analysis:


The results obtained were tabulated for the values of Mean ± SD and statistically analyzed with paired t-test using computer software, SPSS version 12.0. 3. Result: The demographic and physical characteristics of the recruited subjects have not shown any significant difference between the intervention group and control group (Table-1). It was found that there were elevated levels in Fasting Blood Glucose in the diabetes subjects compared to Control Group at ‘0’day. When the Fasting Blood sugar levels in the supplemented Group were compared with Non-Supplemented and Control Group, there was a significant decrease after probiotic supplementation indicating the additive effect of Probiotics along with their regular treatment in the management of Blood Glucose Levels. It was also observed that ADA levels are elevated levels in the above diabetic subjects when compared to healthy controls. In the supplemented group the ADA levels were significantly decreased but not to the extent of normal levels. In non-supplemented group the ADA levels did not show any significant changes between 0 & 30 days. However, there was no significant difference in healthy controls. Table:1 Characteristics of the Subjects studied S.NoCharacteristics SupplementedNon Control Group SupplementedGroup Group 1 No. of 18 18 14 Subjects A Males 11 12 10 B Females 7 6 4 2 Age 53.4±6.81 54.8±2.97 52 ±3.91 (Mean SD) 3 Weight(Kgs 73.04±8.6 76.4±5.25 70.2±5.7 ) (Mean SD) 7 9 4 Height(cms) 163.6±6.9 164.3±5.2 162.2±2. (Mean SD) 7 3 9 5 BMI 27.2 ± 28.21±1.7 26.6±1.9 (Mean SD) 2.45 5 6 *no significant difference between Subjects and controls

Table:2 Effect of Probiotic Curd on Fasting Blood Glucose Category Group A1 (Diabetic Supplemented) Group A2 (Diabetic NonSupplemented)

No. of Subjects 18

Blood Glucose 0 Day 157.95±

30 Day 134.5 40.7

83.99 18

±

b

a

a

172.8 ±73.6

c

203.7± 84.7

Page 1245

Imperial Journal of Interdisciplinary Research (IJIR) Vol-3, Issue-4, 2017 ISSN: 2454-1362, http://www.onlinejournal.in c

c

In a recent study conducted by researchers of Cornell University discovered a probiotic, commonly found in the human gut, can 'rewire' the body to help combat diabetes. The probiotic treatment lowered Normal values: FBS: 70 -110 mg/dl diabetic rats' blood glucose levels by up to 30%. *Difference in the superscript indicate statistical Scientists say higher doses could reverse both type 1 significance within and between the groups at P<0.05 and 2 diabetes. In the same study done by the scientists of Cornell Table:3 University it was observed that the serum ADA Immunomodulation in Supplemented Group activity was increased with an increase in insulin Adenosine deaminase resistance in the diabetic population. ADA may be Category No. Activity (U/L) used as a marker of insulin resistance and can be Subjec0 Day 30 Day employed as an effective tool in screening for insulin s resistance in diabetes mellitus. a Group A1 18 27.03±7.36 In addition to the above data the present study 33.2± 6.30 b (Diabetic showed the additive effect of probiotic curd along (altered) Supplemented) with the regular medication in the maintenance of (altered) a blood glucose levels and immunomodulation in the Group A2 18 30.81±2.56 34 ± 3.76 a subjects with type-2 diabetes mellitus. It can be (Diabetic (altered) noted that since there are a number of probiotics NonSupplemente (altered) available with large and narrow spectrum of activity, d) C different combinations and prolonged period of Group B 14 20.68±4.26 18.2 ± 5.6 supplementation may be tried for better beneficial c (Healthy effects. Controls) Group B (Healthy Controls)

14

90.03± 8.00

85.87±8.73

5. Conclusion Normal values: ADA: 15 -25 U/l *Difference in the superscript indicate statistical Diabetes can usually be controlled with the right significance within and between the groups at P<0.05 diet and medication. If we keep a close eye on the disease and our blood glucose levels we can greatly minimize the risk of further complications. 4. Discussion Probiotics are GRAS (Generally Recognized As Safe) microorganisms which can be used for the Probiotics are live microorganisms which confer management of diabetes. From this study it can be health benefits when taken in adequate amount concluded that Probiotic Curd (Indian Dahi) has (WHO) [9]. Modulation of intestinal microbiota by immense beneficial effect in the management of T2 probiotics may facilitate the management of many DM, which has dual affect i.e. Blood Glucose and clinical conditions [10]. Probiotics are also involved immune status. However, it is advisable to take food in the maintenance of a healthier gut microbiota, and based probiotic supplements rather than drug based have also been identified as effective adjuvants in to obtain better beneficial effects in DM subjects. insulin resistance therapies [11,12]. These are often It also be concluded that supplementation of proved for their different beneficial effects as antiprobiotic curd eventually maintained the levels of diarrheal [13], anti-cancerous [14], antimicrobial ADA and thus imparting immuno-modulatory [15], hypocholesteraemia [16] and antidiabetic etc. In activity. The data also suggests that an increasing a study, Lactobacillus GG was shown the effort should be made to understand the cellular and antidiabetic effect in diabetic rats [17]. In other study molecular mechanisms behind the role played by conducted in Saudi Arabia, a combination of probiotic organisms for identifying their other probiotics has shown the potential benefits on benefits. circulating endotoxin levels and other markers for The detailed studies in this area will bring systemic low-grade inflammation in patients with newer dimensions to the projected area of safe and T2DM [18]. Earlier our own study has shown the natural probiotic microflora. Our studies are effect of probiotic curd on the management of lipid providing a foundation that may lead to new profile on obese subjects [19]. The mechanisms approaches for diagnosing, preventing and treating associated with gut flora–mediated pathology of diabetes mellitus in addition to development of new obesity and diabetes are through (1) increased energy nutritional formulations. Our findings also give a harvest, (2) increased blood LPS levels scope to further carry out studies on large number of (endotoxemia), and (3) low-grade inflammation [20]. diabetic subjects and to evaluate the beneficial role Therefore, modulation of gut flora has been of Probiotic microflora for better management of considered as a potential target to treat against diabetes mellitus. diabetes associated obesity.


Page 1246

Imperial Journal of Interdisciplinary Research (IJIR) Vol-3, Issue-4, 2017 ISSN: 2454-1362, http://www.onlinejournal.in 6. Acknowledgements We wish to acknowledge Dr (Mrs) Ratna Sudha Managing Director of Unique Biotech Private Limited, Hyderabad, India for supplying the required probiotics at free of cost. We wish to thank Mr.T.Longvah, the Director- in- charge, NIN, for encouraging the present study.

10.

11.

7. References 1.

2.

3.

4.

5.

6.

7.

8. 9.

IDF Diabetes Atlas. 6th edn. Brussels, Belgium: International Diabetes Federation; 2013.URLhttp://www.idf.org/sites/default/fil es/EN_6E_Atlas_Full_0.pdf [accessed on 18 March 2014] Martinez-Hernandez D, Arenas-Barbero J, Navarro-Gallar F, Garcia-Esteban R, SantosSancho JM, Gomez-de-Terreros FJ. Adenosine deaminase in acquired immunodeficiency syndrome [letter] Clin Chem. 1988; 34: 1949. Panwar H, Rashmi HM, Batish VK, Grover S. Probiotics as potential biotherapeutics in the management of type 2 diabetes prospects and perspectives. Diabetes Metab Res Rev. 2013 Feb;29(2):103-12. Yadav H, Jain S, Sinha PR. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition. 2007 Jan;23(1):62-8. Zhang Q, Wu Y, Fei X. Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. Medicina (Kaunas). 2016;52(1):28-34. Ostadrahimi A, Taghizadeh A, Mobasseri M3, Farrin N, Payahoo L, Beyramalipoor Gheshlaghi Z, Vahedjabbari M. Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: a randomized double-blind placebocontrolled clinical trial. Iran J Public Health 2015 Feb;44(2):228-37. Barham D, Trinder P. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst. 1972 Feb;97(151):142-5. Giusti, G., Galanti, B., Methods of Enzymatic Analysis, Pg. 1092 – 1099. Schlundt, Jorgen. "Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria". Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic


12.

13.

14.

15.

16.

17.

18.

19.

Acid Bacteria. FAO/WHO. October 22, 2012. Retrieved 17 December 2012. Floch MH, Montrose DC: Use of probiotics in humans: an analysis of the literature. Gastroenterol Clin North Am. 2005, 34: 547570. Moroti C, Souza Magri LF, Costa MR, Cavallini DC, Sivieri K: Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis. 2012, 11: 29 Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V: Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 2012, 28: 539-543. Mary Hickson, Aloysius L D'Souza, Nirmala Muthu, Thomas R Rogers, Susan Want, Chakravarthy Rajkumar and Christopher J Bulpitt. Use of Probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007 Jul 14; 335(7610): 80. Nami Y, Abdullah N, Haghshenas B, Radiah D, Rosli R, Khosroushahi AY. Assessment of probiotic potential and anticancer activity of newly isolated vaginal bacterium Lactobacillus plantarum 5BL. Microbiol Immunol. 2014 Sep;58(9):492-502. R. Denkova, Z. Denkova, V. Yanakieva1, D. Blazheva. Antimicrobial activity of probiotic lactobacilli, bifidobacteria and propionic acid bacteria, isolated from different sources. Microbial pathogens and strategies for combating them: science, technology and education. 2013, pg.no:857-864. Nguyen TDT., Kang JH. and Lee MS. Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. International Journal of Food Microbiology. 113 (3). 358361 Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M, et al. Antidiabetic effect of Lactobacillus GG in streptozotocininduced diabetic rats. Bioscience, biotechnology, and biochemistry. 2003; 67(6):1421–4. Majed S Alokail, Shaun Sabico, Yousef AlSaleh , Nasser M Al-Daghri, Khalid M Alkharfy, Paul M Vanhoutte and Philip G McTernan. Effects of probiotics in patients with diabetes mellitus type 2: study protocol for a randomized, double-blind, placebocontrolled trial. Trials 2013, 14:195 Shiva Prakash M, Madhavi.G and Hemalatha.R. Effect of supplementation of Page 1247

Imperial Journal of Interdisciplinary Research (IJIR) Vol-3, Issue-4, 2017 ISSN: 2454-1362, http://www.onlinejournal.in probiotic curd on lipid profile in obese subjects. IJFANS Vol.3, Iss.4, Jul-Sep 2014. Pg.no 148-152. 20. Delzenne NM, Neyrinck AM, Ba ̈ckhed F & Cani PD (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7: 639–646.


Page 1248

EFFECT OF PROBIOTIC SUPPLEMENTATION ON THE FASTING BLOOD

Recommend Documents